Efficacy of Afatinib in the Treatment of Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Efficacy of Afatinib in the Treatment of Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Several randomized controlled trials (RCTs) evaluated the afatinib efficacy in patients with advanced non-small cell lung cancer (NSCLC) and recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). This review systemically outlined and meta-analyzed the afatinib efficacy in NSCLC and...

Full description

Bibliographic Details
Main Authors: Nian N. N. Maarof, Abdulsamad Alsalahi, Emilia Abdulmalek, Sharida Fakurazi, Bimo Ario Tejo, Mohd Basyaruddin Abdul Rahman
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
afatinib
randomized clinical trials
non-small cell lung cancer
head and neck squamous cell carcinoma
Online Access:https://www.mdpi.com/2072-6694/13/4/688

Internet

https://www.mdpi.com/2072-6694/13/4/688

Similar Items